The MHRA has launched a 2026 consultation on the future of CE marking in Great Britain, proposing its indefinite recognition for medical devices. The outcome could significantly impact regulatory requirements.
UK MHRA and US FDA strengthen collaboration to advance AI innovation in medical technology
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced new steps to reinforce its collaboration with the US Food and Drug Administration (FDA).